Ads
related to: xalatan eye drops- Savings Offer Available
Eligible Patients May Pay As Little
As $25 Copay For A 90-Day Supply.
- Access & Dosing
Help Your Patients Get Access
To Treatment. View Dosing Info.
- Mechanism of Action
See How VYZULTA Works.
Watch Quick Video.
- Resources
Browse Videos. Download Resources
For Eye Care Professionals.
- Savings Offer Available
goodrx.com has been visited by 100K+ users in the past month
"GoodRx can help you save, whether you have insurance or not." - Patch
Search results
Results From The WOW.Com Content Network
Latanoprost. Latanoprost, sold under the brand name Xalatan among others, is a medication used to treat increased pressure inside the eye (intraocular pressure). [5] This includes ocular hypertension and open-angle glaucoma. [5] Latanaprost is applied as eye drops to the eyes. [5] Onset of effects is usually within four hours, and they last for ...
D07505. CompTox Dashboard (EPA) DTXSID401005716. Latanoprost/timolol, sold under the brand name Xalacom, is a combination drug used for the treatment of glaucoma, consisting of latanoprost (increase uveoscleral outflow of aqueous humor [3]) and timolol (a beta blocker decreasing the production of aqueous fluid).
Dorzolamide/timolol, sold under the brand name Cosopt among others, is a medication used to treat high pressure inside the eye including glaucoma. It is a combination of dorzolamide hydrochloride and timolol maleate. It may be used when a beta blocker, like timolol, is not sufficient alone. It is used as an eye drop.
Netarsudil/latanoprost, sold under the brand name Rocklatan among others, is a fixed-dose combination medication use to treat elevated intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension. It contains netarsudil mesylate and latanoprost. It is applied as eye drops to the eyes.
Latanoprostene bunod. Latanoprostene bunod (trade name Vyzulta) is an ophthalmic drug approved in the United States in 2017 for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. [3] [4] It targets the trabecular meshwork directly. [4]
Netarsudil, sold under the brand name Rhopressa among others, is a medication for the treatment of glaucoma. [1] [2] [3] In the United States, in December 2017, the Food and Drug Administration (FDA) approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension.